» Articles » PMID: 28207884

Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0162866.].

Citing Articles

Actionable Pharmacogenetic Variation in the Slovenian Genomic Database.

Hocevar K, Maver A, Peterlin B Front Pharmacol. 2019; 10:240.

PMID: 30930780 PMC: 6428035. DOI: 10.3389/fphar.2019.00240.


Genetic polymorphisms in aquaporin 1 as risk factors for malignant mesothelioma and biomarkers of response to cisplatin treatment.

Senk B, Goricar K, Kovac V, Dolzan V, Franko A Radiol Oncol. 2019; 53(1):96-104.

PMID: 30840592 PMC: 6411020. DOI: 10.2478/raon-2019-0009.

References
1.
Mizzi C, Dalabira E, Kumuthini J, Dzimiri N, Balogh I, Basak N . A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics. PLoS One. 2016; 11(9):e0162866. PMC: 5026342. DOI: 10.1371/journal.pone.0162866. View